GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » EV-to-EBITDA

Cytori Cell Research Institute (TSE:3750) EV-to-EBITDA : -18.79 (As of Jun. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cytori Cell Research Institute's enterprise value is 円15,662 Mil. Cytori Cell Research Institute's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円-833 Mil. Therefore, Cytori Cell Research Institute's EV-to-EBITDA for today is -18.79.

The historical rank and industry rank for Cytori Cell Research Institute's EV-to-EBITDA or its related term are showing as below:

TSE:3750' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7325.49   Med: 1.39   Max: 696.51
Current: -18.79

During the past 13 years, the highest EV-to-EBITDA of Cytori Cell Research Institute was 696.51. The lowest was -7325.49. And the median was 1.39.

TSE:3750's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Biotechnology industry
Industry Median: 8.545 vs TSE:3750: -18.79

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-23), Cytori Cell Research Institute's stock price is 円965.00. Cytori Cell Research Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-99.669. Therefore, Cytori Cell Research Institute's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cytori Cell Research Institute EV-to-EBITDA Historical Data

The historical data trend for Cytori Cell Research Institute's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute EV-to-EBITDA Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.99 25.71 -76.45 53.79 -24.82

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.99 -24.82 -18.62 -20.33 -20.66

Competitive Comparison of Cytori Cell Research Institute's EV-to-EBITDA

For the Biotechnology subindustry, Cytori Cell Research Institute's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's EV-to-EBITDA falls into.



Cytori Cell Research Institute EV-to-EBITDA Calculation

Cytori Cell Research Institute's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=15661.840/-833.363
=-18.79

Cytori Cell Research Institute's current Enterprise Value is 円15,662 Mil.
Cytori Cell Research Institute's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-833 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute  (TSE:3750) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cytori Cell Research Institute's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=965.00/-99.669
=At Loss

Cytori Cell Research Institute's share price for today is 円965.00.
Cytori Cell Research Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-99.669.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cytori Cell Research Institute EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines